The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 926
ISSUE 926
July 8, 1994
Issue 926
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Granisetron to Prevent Vomiting After Cancer Chemotherapy
July 8, 1994 (Issue: 926)
Granisetron, a serotonin (5-HT) antagonist similar to ondansetron, was recently approved by the US Food and Drug Administration for prevention of nausea and vomiting due to cancer chemotherapy. Although available in an oral formulation in other...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.